A5079464976- Cutaneous lymphoproliferative disorders research
- Fungal Infections and Studies
- Nail Diseases and Treatments
- Dermatologic Treatments and Research
- Vascular Tumors and Angiosarcomas
- Facial Rejuvenation and Surgery Techniques
- melanin and skin pigmentation
- T-cell and Retrovirus Studies
- Lymphoma Diagnosis and Treatment
- Infectious Diseases and Mycology
- Heparin-Induced Thrombocytopenia and Thrombosis
- Nanoplatforms for cancer theranostics
- Immunotherapy and Immune Responses
- Stoma care and complications
- Extracellular vesicles in disease
- Inflammatory Bowel Disease
- CAR-T cell therapy research
- Hair Growth and Disorders
- Eosinophilic Disorders and Syndromes
- Skin Protection and Aging
- T-cell and B-cell Immunology
- Drug-Induced Adverse Reactions
- Blood disorders and treatments
- Cutaneous Melanoma Detection and Management
- Mast cells and histamine
Tel Aviv University
2020-2025
Rabin Medical Center
2020-2023
Marconi University
2019
European Organisation for Research and Treatment of Cancer
2018
UPMC Hillman Cancer Center
2013
University of Pittsburgh
2013
Survival in mycosis fungoides (MF) is varied and may be poor. The PROCLIPI (PROspective Cutaneous Lymphoma International Prognostic Index) study a web-based data collection system for early-stage MF with legal data-sharing agreements permitting international collaboration rare cancer complex pathology. Clinicopathological must 100% complete in-built intelligence the database ensures accurate staging.
Abstract Background Ileo-cecal resection is an effective treatment in Crohn’s patients, while diarrhea a common postoperative negative outcome, with significant effect on patient’s quality of life. The aim this study to assess the pre, peri and post-operative variables number post-surgical bowel movements. Methods A retrospective cohort 168 patients undergoing primary ileo-cecal (2015–2023) at high-volume center (Rabin Medical Center). Bowel movements were analyzed three intervals (first...
Literature regarding the effect of biologics on course mycosis fungoides (MF) is scarce. This multicentre study analysed retrospective data 19 patients with MF, who were treated biologics; 12 for inflammatory conditions coexisting and 7 MF misdiagnosed as an skin disease. Eight anti-tumour necrosis factor-?-monotherapy; 6 had early-stage in 3 preceded was diagnosed after initiation biologics, no stage-progression or stable disease, respectively (median treatment time concurrent 57 months)....
Real-life efficacy data on the recently approved once daily application of chlormethine gel (CG) for mycosis fungoides (MF) is limited, and detailed characterization side effects their management are strikingly sparse.To evaluate particularly effect profile CG in early-stage MF patients a real-life setting.We performed single-center retrospective analysis 66 adult treated with 2016-2019.Treatment once-daily (52%), or at lower frequencies (48%), some topical corticosteroids (TCS) (40%),...
Microneedling fractional radiofrequency (FRF) and chemical peels are widely used for skin rejuvenation.The authors aimed at evaluating the efficacy safety of FRF trichloroacetic acid 20% (TCA20%) peel in different combinations determining optimal treatment protocol.In this prospective clinical comparison 4 protocols (FRF alone, TCA20% before [TCA→FRF], following [FRF→TCA]), patients underwent 3.8 ± 1.2 successive treatments one protocol 4- to 6-week intervals. The 2 dermatologists evaluated...
Mycosis fungoides (MF) and Sézary syndrome (SS) are the most common types of primary cutaneous T-cell lymphoma (CTCL). Proliferating cell nuclear antigen (PCNA) is expressed on surface cancer cells (csPCNA), but not normal cells. It functions as an immune checkpoint ligand by interacting with natural killer (NK) through NK inhibitory receptor NKp44, leading to inhibition cytotoxicity. A monoclonal antibody (mAb14) was established detect csPCNA block their interaction NKp44. In this study,...
Dermatochalasis (DC) is part of the aging process eyelids, characterized by lax, redundant, and overhanging excess eyelid skin. Mostly, it treated surgical blepharoplasty. Lately alternative nonsurgical blepharoplasty technologies have been introduced. In this study, we evaluated efficacy safety a novel noninvasive RF microplasma technology for upper DC. A prospective single center study included 17 patients with moderate to severe Subjects were controlled micro-plasma sparks via tip leading...
Patients with mycosis fungoides (MF) are thought to be at increased risk of melanoma. However, studies addressing surveillance-bias and treatments as a possible confounder lacking. This retrospective study compared the prevalence melanoma between 982 patients MF, 3,165 psoriasis attending tertiary cutaneous-lymphoma/psoriasis clinics during 2009 2018. Melanoma was diagnosed in 47 MF (4.8%; 43 early-stage) 23 (0.7%) (odds ratio 6.6, p < 0.0001). In 60% patients, MF/psoriasis preceded...
<b><i>Background:</i></b> Mycosis fungoides (MF) in solid-organ transplant recipients (SOTRs) is rare, with limited data on disease characteristics. <b><i>Objective:</i></b> The aim was to study the characteristics of MF SOTRs an emphasis immunosuppressive therapy. <b><i>Methods:</i></b> A retrospective cohort patients diagnosed MF, who were also SOTRs, followed at 3 cutaneous lymphoma outpatient clinics, between January...
Background . Psoralen plus ultraviolet A (PUVA) is the preferred phototherapeutic modality for early‐stage folliculotropic mycosis fungoides (FMF), and non‐FMF refractory to narrow‐band B (NBUVB). However, PUVA has a problematic safety profile. Literature on treatment with combination of UVA NBUVB MF sparse. Objective To evaluate effectiveness combined MF, specifically FMF NBUVB‐refractory non‐FMF, in adult pediatric patients. Methods retrospective analysis was conducted patients treated at...